Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corporation, a residential real estate finance company, acquires, invests in, and manages residential mortgage assets in the United States. The company operates through Investments in RMBS (residential mortgage-backed securities), Investments in Servicing Related Assets, and All Other segments. It manages a portfolio of servicing related assets and RMBS. Cherry Hill Mortgage Investment Corporation qualifies as a real estate investment trust for federal income tax purposes. The company generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Cherry Hill Mortgage Investment Corporation was incorporated in 2012 and is based in Farmingdale, New Jersey.

Cherry Hill Mortgage Investment Corporation trades as CHMI on NYSE. The company is classified in Real Estate / REIT - Mortgage and reports in USD.

The current profile places the business in REIT - Mortgage. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $105.39M of revenue and $6.83M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Cherry Hill Mortgage Investment Corporation can be compared against peers such as Advanced Flower Capital Inc., Altisource Portfolio Solutions S.A., Clipper Realty Inc., Global Medical REIT Inc., Granite Point Mortgage Trust Inc., Intelicare Holdings Ltd.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $86.34M, beta of 1.03, and return on equity of +2.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CHMI currently shows total debt of $1.28B and beta of 1.03. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 4 (2026-06-03 00:00:00), 8-K (2026-05-07 00:00:00), 10-Q (2026-05-07 00:00:00), 4 (2026-04-23 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.chmireit.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.